Genentech’s Rituxan Fails Against PPMS

Late-stage lupus trial is still a wild card for anti-B-cell therapy.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet